LANDING ADVANCE
LIVE

Serial Number

79373120

Owner

EUROSETS S.r.l.

Attorney

Andrew T. Rissler

Filing Date

Feb 8, 2023

Add to watchlist:

No watchlists yet
View on USPTO

LANDING ADVANCE Trademark

Serial Number: 79373120 • Registration: 8081457

LANDING ADVANCE is a trademark filed by EUROSETS S.r.l. on February 8, 2023. The trademark is classified under Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

EUROSETS S.r.l. (20 trademarks)

Strada Statale 12, 143

Entity Type: 16

Trademark Details

Filing Date

February 8, 2023

Registration Date

December 30, 2025

Published for Opposition

November 11, 2025

Goods & Services

Data processing equipment in relation to the field of medicine, biomedicine and hospitals; computer hardware in relation to the fields of medicine, biomedicine and hospitals; computer software platforms, recorded and downloadable, in relation to the fields of medicine, biomedicine and hospitals for use with medical devices for monitoring blood oxygen, patients' vital parameters,hemodynamic and metabolic parameters of patients,cardiopulmonary activity, extracorporeal life support, extracorporeal membrane oxygenation, extracorporeal life support procedures, cardiopulmonary bypass procedures, and extracorporeal membrane oxygenation procedures; downloadable software for medical use, namely, for use with medical devices for monitoring blood oxygen, patients' vital parameters, hemodynamic and metabolic parameters of patients, cardiopulmonary activity, extracorporeal life support, extracorporeal membrane oxygenation, extracorporeal life support procedures, cardiopulmonary bypass procedures and extracorporeal membrane oxygenation procedures; downloadable software in relation to the field of biomedicine and hospitals for use with medical devices for monitoring blood oxygen, patients' vital parameters, hemodynamic and metabolic parameters of patients, cardiopulmonary activity, extracorporeal life support, extracorporeal membrane oxygenation, extracorporeal life support procedures, cardiopulmonary bypass procedures and extracorporeal membrane oxygenation procedures

Surgical and medical apparatus and instruments, namely apparatus and instruments for monitoring blood oxygen, apparatus and instruments for monitoring patients' vital parameters, apparatus and instruments for monitoring hemodynamic and metabolic parameters of patients being cardiopulmonary by-pass (CPB) activity and Extra-Corporeal Life Support (ECLS) activity, apparatus and instruments for monitoring cardiopulmonary activity, apparatus and instruments for extracorporeal membrane oxygenation, apparatus and instruments for monitoring extracorporeal life support activity, apparatus and instruments for monitoring extracorporeal membrane oxygenation procedures being monitors which measure and assess data about the carbon dioxide removed by the artificial lung compared to the carbon dioxide removed by the natural lung, apparatus and instruments for monitoring cardiopulmonary bypass procedures being extracorporeal monitors for heart rate, for calculated and measured hemodynamic parameters, for calculated and measured hematological parameters and for calculated and measured respiratory parameters

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Jul 23, 2026 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jul 6, 2026 FICS
FINAL DISPOSITION PROCESSED
Jul 6, 2026 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Mar 30, 2026 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Dec 30, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Dec 30, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 11, 2025 NPUB
PUBLISHED FOR OPPOSITION
Nov 11, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 5, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 15, 2025 CNSA
EXAMINER'S AMENDMENT ENTERED
Oct 15, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Oct 15, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
Oct 15, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
Oct 15, 2025 CNEA
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Sep 7, 2025 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Mar 6, 2025 GNS3
LETTER OF SUSPENSION E-MAILED
Mar 6, 2025 GNSL
SUSPENSION LETTER WRITTEN
Mar 6, 2025 CNSL
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Feb 28, 2025 OPNX
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 5, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 4, 2025 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Feb 4, 2025 ERFR
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Feb 3, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Feb 3, 2025 OPNR
NOTIFICATION OF FINAL REFUSAL EMAILED
Aug 9, 2024 GNFN
FINAL REFUSAL E-MAILED
Aug 9, 2024 GNFR
FINAL REFUSAL WRITTEN
Aug 9, 2024 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
May 15, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 15, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 15, 2024 TROA
REFUSAL PROCESSED BY IB
Dec 4, 2023 RFNP
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Nov 15, 2023 RFCS
REFUSAL PROCESSED BY MPU
Nov 15, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 15, 2023 RFCR
NON-FINAL ACTION WRITTEN
Nov 14, 2023 CNRT
ASSIGNED TO EXAMINER
Nov 7, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
Jul 18, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 12, 2023 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Jul 10, 2023 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jun 29, 2023 REPR